GridAI Technologies GRDX
NASDAQ GRDX
$2.97 -0.05 (-1.66%)
At close: Sep 10, 2026 · 4:00 PM EDT

GridAI Technologies (GRDX) Total Debt (2015 - 2026)

GridAI Technologies' (GRDX) quarterly Total Debt came in at $7.9 million in Q2 2026, up 1032.34% on a YoY basis from $700000.0 in Q2 2025, and down 4.24% quarter-over-quarter from $8.3 million in Q4 2025.

Analysis

GridAI Technologies (GRDX) Total Debt (2015 - 2026) Analysis & Trends

GridAI Technologies (GRDX) has reported Total Debt for 12 consecutive years, with $7.9 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Total Debt rose 1032.34% year-over-year to $7.9 million; the trailing twelve-month figure through Jun 2026 stood at $7.9 million (up 1032.34% YoY), and the FY2025 full-year result was $8.3 million, changed N/A from the prior year.
  • Total Debt retreated to $7.9 million in Q2 2026 per GRDX's latest filing, from $8.3 million in the prior quarter.
  • Across five years, Total Debt topped out at $8.3 million in Q4 2025 and bottomed at $153478.0 in Q2 2023.
  • Historically, Total Debt has averaged $2.2 million across 5 years, with a median of $612784.0 in 2023.
  • The sharpest annual moves came in 2024 and 2025: Total Debt soared 1683.61% in 2024, then plunged 89.68% in 2025.
  • Over 5 years, Total Debt stood at $603494.0 in 2022, then advanced by 1.54% to $612784.0 in 2023, then sank by 71.02% to $177563.0 in 2024, then soared by 4561.55% to $8.3 million in 2025, then decreased by 4.24% to $7.9 million in 2026.
  • According to Business Quant data, Total Debt over the past three periods registered $7.9 million, $8.3 million, and $2.0 million for Q2 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn 62.75 Bn
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn 28.66 Bn
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn -
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn 1.99 Bn
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn -
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn 591.00 Mn
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn -
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn 8.09 Bn
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn -
10 GridAI Technologies 19.07 Mn 19.07 Mn -36,514.00 7.93 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 7.93 Mn
Dec 31, 2025 8.28 Mn
Sep 30, 2025 2.00 Mn
Jun 30, 2025 700,000.00
Mar 31, 2025 700,000.00
Jun 30, 2024 177,563.00
Mar 31, 2024 6.78 Mn
Dec 31, 2023 612,784.00
Jun 30, 2023 153,478.00
Mar 31, 2023 380,390.00
Dec 31, 2022 603,494.00
Jun 30, 2022 161,909.00
Mar 31, 2022 402,766.00
Dec 31, 2021 641,236.00
Jun 30, 2021 279,138.00
Mar 31, 2021 694,164.00
Dec 31, 2020 1.10 Mn
Sep 30, 2020 38,453.00
Jun 30, 2020 622,462.00
Mar 31, 2020 956,469.00